The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Predictive Factors for Hypertrophy of the Future Remnant Liver After Selective Portal Vein Embolization
Abstract
Background To analyze predictive factors of hypertrophy of the nonembolized future remnant liver (FRL) after transhepatic preoperative portal vein embolization (PVE) of the liver to be resected.Materials and methods Age, gender, indocyanin green clearance test, chemotherapy before PVE, type of chemotherapy, operators, extent of PVE, radiofrequency ablation (RFA) associated with PVE, time delay between PVE and surgery, and platelet count were retrospectively evaluated as predictive factors for hypertrophy of FRL in 107 patients with malignant disease in noncirrhotic liver. PVE targeted the right liver lobe [n = 70] or the right liver lobe and segment IV [n = 37] when FRL/total liver volume ratio was below 25% in healthy liver or 40% in altered liver.Results After PVE, FRL volume significantly increased by 69%, from 344 +/- 156 cm(3) to 543 +/- 192 cm(3) (P < .0001). The degree of hypertrophy was negatively correlated with FRL volume (correlation coefficient = -0.55, P < .0001) and FRL/TFL ratio (correlation coefficient = -0.52, P < .0001) before PVE. Patients, who have undergone chemotherapy with platin agents prior to PVE, demonstrated lower hypertrophy (P = .048).Conclusion Hypertrophy after PVE is inversely correlated to initial FRL volume. Hypertrophy of the liver might be influenced by the systemic chemotherapeutic received before PVE.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Predictors of response were a size of <3 cm and high lipidol uptake.”
From Adrenocortical carcinoma (2014) · cites this paper as [357]
In the citing paper
“In the largest series to date, 103 lesions in 29 patients were treated with response in 21% of patients and stabilization in 62% (357).”
From Adrenocortical carcinoma (2014) · cites this paper as [357]
Citations
Cites
Rescue Surgery for Unresectable Colorectal Liver Metastases Downstaged by Chemotherapy
Adam, R. A., Delvart, V., Pascal, G., Valeanu, A., Castaing, D., Azoulay, D., Giacchetti, S., Paule, B., Kunstlinger, F., Ghémard, O., et al. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000141198.92114.f6 · Cited by 1,478
Liu, B., Ying, J., Luo, C., Xu, Q., Zhu, L., & Zhong, H. (2012) · Hepatogastroenterology · doi:10.5754/hge11893 · Cited by 1,338
Vauthey, J., Pawlik, T. M., Ribero, D., Wu, T., Zorzi, D., Hoff, P. M., Xiong, H. Q., Eng, C., Lauwers, G. Y., Mino-Kenudson, M. A., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.3074 · Cited by 1,302
Rubbia‐Brandt, L., Audard, V., Sartoretti, P., Roth, A., Brézault, C., Charpentier, M. L., Dousset, B. E., Morel, P., Soubrane, O., Chaussade, S., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh095 · Cited by 1,032
Tumor Progression While on Chemotherapy
Adam, R. A., Pascal, G., Castaing, D., Azoulay, D., Delvart, V., Paule, B., Lévi, F., & Bismuth, H. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000145964.08365.01 · Cited by 999
Platelet-Derived Serotonin Mediates Liver Regeneration
Lesurtel, M., Graf, R., Aleil, B., Walther, D. J., Tian, Y., Jochum, W., Gachet, C., Bäder, M., & Clavien, P. (2006) · Science · doi:10.1126/science.1123842 · Cited by 800
Karoui, M., Penna, C., Amin-Hashem, M., Mitry, E., Benoist, S., Franc, B., Rougier, P. R., & Nordlinger, B. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000193603.26265.c3 · Cited by 719
Nagino, M., Kamiya, J., Nishio, H., Ebata, T., Arai, T., & Nimura, Y. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000201482.11876.14 · Cited by 540
Azoulay, D., Castaing, D., Smail, A., Adam, R. A., Cailliez, V., Laurent, A., Lemoine, A., & Bismuth, H. (2000) · Annals of Surgery · doi:10.1097/00000658-200004000-00005 · Cited by 538
Volumetric Analysis Predicts Hepatic Dysfunction in Patients Undergoing Major Liver Resection
Shoup, M. C., Gönen, M., D'Angelica, M. I., Jarnagin, W. R., DeMatteo, R. P., Schwartz, L. H., Tuorto, S., Blumgart, L. H., & Fong, Y. (2003) · Journal of Gastrointestinal Surgery · doi:10.1016/s1091-255x(02)00370-0 · Cited by 510
Cited by
Sorted by citations
Schnitzbauer, A. A., Lang, S. A., Goessmann, H., Nadalin, S., Baumgart, J., Farkas, S. A., Fichtner‐Feigl, S., Lorf, T., Goralcyk, A., Hörbelt, R., et al. (2012) · Annals of Surgery · doi:10.1097/sla.0b013e31824856f5 · Cited by 1,330
Else, T., Kim, A. C., Sabolch, A., Raymond, V. M., Kandathil, A., Caoili, E. M., Jolly, S., Miller, B. S., Giordano, T. J., & Hammer, G. D. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1029 · Cited by 892
Portal Vein Embolization Before Liver Resection: A Systematic Review
van Lienden, K. P., van den Esschert, J. W., de Graaf, W., Bipat, S., Laméris, J. S., van Gulik, T. M., & van Delden, O. M. (2012) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-012-0440-y · Cited by 472
Garlipp, B., de Baère, T., Damm, R., Irmscher, R., Buskirk, M. V., Stübs, P., Deschamps, F., Meyer, F. P., Seidensticker, R., Mohnike, K., et al. (2013) · Hepatology · doi:10.1002/hep.26947 · Cited by 166
Eshmuminov, D., Raptis, D. A., Linecker, M., Wirsching, A., Lesurtel, M., & Clavien, P. (2016) · British journal of surgery · doi:10.1002/bjs.10290 · Cited by 157
Metadata
- Authors
- de Baere, T., Teriitehau, C., Deschamps, F., Catherine, L., Rao, P., Hakime, A., Auperin, A., Goere, D., Elias, D., & Hechelhammer, L.
- Affiliations
- Institut Gustave Roussy (FR)
- Venue
- Annals of Surgical Oncology
- Published
- 2010-03-17
- Volume
- 17
- Issue
- 8
- Pages
- 2081-2089
- ISSN
- 1068-9265 (ISSN-L)
- 1534-4681
- OpenAlex
- W2082993378
- Cited by
- 139
- References
- 43
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 7 · 2023: 7 · 2022: 9 · 2021: 10 · 2020: 10 · 2019: 10 · 2018: 10 · 2017: 11 · 2016: 12 · 2015: 8 · 2014: 8 · 2013: 10 · 2012: 12
- FWCI
- 5.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Annals of Surgical Oncology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
- Keywords
- liver hypertrophy, predictive factors, hepatectomy, non-cirrhotic liver, neoadjuvant chemotherapy, platinum agents, indocyanine green clearance, radiofrequency ablation
- MeSH terms
- Adolescent, Adult, Aged, Embolization, Therapeutic, Female, Hepatectomy, Humans, Hypertrophy, Liver, Liver Neoplasms, Male, Middle Aged, Portal Vein, Retrospective Studies, Treatment Outcome, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
